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Abstract:  Iodine  is  an  integral  part  of  the  thyroid  hormones,  thyroxine  (T4)  and  
tri-iodothyronine (T3), necessary for normal growth and development. An adequate supply 
of cerebral T3, generated in the fetal brain from maternal free T4 (fT4), is needed by the 
fetus for thyroid hormone dependent neurodevelopment, which begins in the second half of 
the first trimester of pregnancy. Around the beginning of the second trimester the fetal 
thyroid also begins to produce hormones but the reserves of the fetal gland are low, thus 
maternal thyroid hormones contribute to total fetal thyroid hormone concentrations until 
birth. In order for pregnant women to produce enough thyroid hormones to meet both her 
own and her baby’s requirements, a 50% increase in iodine intake is recommended. A lack 
of iodine in the diet may result in the mother becoming iodine deficient, and subsequently 
the fetus. In iodine deficiency, hypothyroxinemia (i.e., low maternal fT4) results in damage 
to  the  developing  brain,  which  is  further  aggravated  by  hypothyroidism  in  the  fetus.  
The most serious consequence of iodine deficiency is cretinism, characterised by profound 
mental  retardation.  There  is  unequivocal  evidence  that  severe  iodine  deficiency  in 
pregnancy impairs brain development in the child. However, only two intervention trials 
have  assessed  neurodevelopment  in  children  of  moderately  iodine  deficient  mothers 
finding improved neurodevelopment in children of mothers supplemented earlier rather 
than  later  in  pregnancy;  both  studies  were  not  randomised  and  were  uncontrolled.  
Thus,  there  is  a  need  for  well-designed  trials  to  determine  the  effect  of  iodine 
supplementation  in  moderate  to  mildly  iodine  deficient  pregnant  women  on 
neurodevelopment in the child. 
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1. Introduction  
Despite considerable progress over the last 25 years, iodine deficiency is still one of the most 
common micronutrient deficiencies in the world today. Iodine deficiency results in a wide spectrum of 
adverse consequences throughout the lifecycle. Of greatest concern is the effect of iodine deficiency 
on the developing brain. The most serious effect of iodine deficiency is cretinism, which occurs in 
women who are severely iodine deficient during pregnancy. The promotion of iodised salt by the 
World Health Organization (WHO) and the International Council for the Control of Iodine Deficiency 
Disorders (ICCIDD) has helped to alleviate endemic cretinism in many parts of the world. Attention is 
now turning to the adverse effects of moderate and mild iodine deficiency in pregnancy. Although 
iodine deficiency in pregnancy will affect both the mother and the child, little attention has been paid 
to the consequences of iodine deficiency on maternal health. This review will describe the role iodine 
plays, via thyroid hormones, in the development of the brain from conception to birth and present 
evidence  of  the  impact  of  severe,  moderate,  and  mild  iodine  deficiency  in  pregnancy  on 
neurodevelopment in the child. 
2. The Role of Thyroid Hormones in Fetal Brain Development 
Iodine  is  essential  for  the  production  of  the  thyroid  hormones,  thyroxine  (T4)  and  the  
3,5,3-triiodothyronine (T3), which are vital for normal growth and development particularly of the 
brain and central nervous system. Maternal thyroid hormones are found in the embryonic cavities 
~4 weeks after conception despite the placenta acting as a barrier designed to prevent excessively high 
levels of free T4 (fT4) and T3 from reaching the fetus before they are needed [1,2]. Thyroid hormones 
are not believed to play a role in very early fetal development as studies have shown that nuclear 
receptors for thyroid hormones are only present in the fetal brain from ~8–9 weeks gestation reaching 
adult levels by 18 weeks gestation [2]. Before midgestation, the mother is the only source of cerebral T3, 
which  is  generated  in  the  fetal  brain  by  type  II  5-iodothyronine  deiodinase  from  maternal  fT4.  
The first stage of thyroid hormone dependent neurodevelopment depends on an adequate supply of 
maternal  fT4,  and  begins  in  the  second  half  of  the  first  trimester.  This  stage  includes  neuronal 
proliferation  and the  onset of  neuronal migration in the  cerebral cortex, hippocampus and  medial 
ganglionic eminence, with the latter processes starting in the first trimester and continuing into the 
early part of the second trimester [2]. Towards the end of the first trimester, in response to high 
concentrations of placental human chorionic gonadotropin (hCG), there is a surge in maternal T4 and 
a decline in thyroid stimulating hormone (TSH), a mechanism thought to ensure that adequate fT4 is 
supplied to the fetus during this period [2,3]. Around the beginning of the second trimester the fetal 
thyroid begins to produce hormones, however, the full development of the pituitary-portal vascular 
system in the fetus does not occur until ~18–20 weeks gestation [1]. The second stage of thyroid 
hormone  neurodevelopment  includes  neurogenesis,  neuron  migration,  axonal  growth,  dendritic 
branching and synaptogenesis, glial cell differentiation and migration, and the onset of myelination [2]. 
The third stage occurs after birth. Although the concentration of T4 in the fetus increases as gestation 
progresses, the reserves of the fetal gland are low and the gland itself does not fully mature until birth, 
thus maternal thyroid hormones continue to contribute to total fetal thyroid hormone concentrations Nutrients 2011, 3  
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until birth. It is no surprise, therefore, that low fT4 occurs in premature babies as they are deprived of 
a maternal supply, and this may partly account for some of the developmental delay often apparent in 
such children [2]. 
A 50% increase in iodine intake is recommended in order for pregnant women to produce enough 
thyroid hormones to meet fetal requirements [4]. A lack of iodine in the diet may result in the mother 
becoming iodine deficient, and subsequently the fetus. The mother and the fetus, however, respond 
differently to this situation, with the mother remaining euthyroid and fetus becoming hypothyroid [3]. 
Iodine deficient pregnant women remain euthyroid for two reasons. Firstly, the increase in maternal 
fT4 that occurs at the end of the first trimester in response to hCG depresses the concentration of 
maternal TSH. Secondly, the maternal thyroid gland responds to a state of relative iodine deficiency by 
invoking the same responses in the thyroid gland as would occur in the non-pregnant state, such as 
increased  iodine trapping, preferential  synthesis of T3  over  T4, hyperplasia, and eventually  goitre. 
Thus, the woman will appear to be euthyroid as both her TSH and T3 concentration will fall within the 
normal reference range. In such situations, localised hypothyroxinemia occurring in specific parts of 
the developing fetal brain is believed to be responsible for the neurodevelopmental damage seen in 
iodine deficiency [5]. The autoregulatary mechanisms available to the mother do not take place in the 
fetus because the fetal gland has not fully matured. Consequently, in the fetus there is a decreased 
synthesis and secretion of T4 and T3, and an increase in the concentration of TSH, resulting in fetal 
hypothyroidism [3]. This explains why neonatal TSH is used as an index of iodine deficiency in 
a population.  
A number of studies have been undertaken in women living in areas of adequate iodine status who 
have low T4 concentrations in pregnancy, usually as a result of thyroid disease in the mother and not 
from iodine deficiency per se. Nonetheless, the assumption made by scientists working in this area is 
that,  regardless  of  the  cause,  the  functional  consequences  of  abnormal  thyroid  hormones  on 
neurodevelopment in the fetus are the same; however, this assumption is untested. In a study of Dutch 
women  with  fT4  <  10th  percentile  during  pregnancy  it  was  found  that  their  children  had  poorer 
psychomotor development at 10 months of age [6], and again at one and two years of age [7] than 
children whose mothers had higher T4 levels in pregnancy. A more recent study found that pregnant 
Dutch women with fT4 < 10th percentile at 12 weeks gestation had infants with significantly lower 
orientation scores as assessed using the Neonatal Behavioural Assessment Scale than mothers with fT4 
between the 50th and 90th percentiles [8]. Zoeller and Rovet discuss the role of thyroid hormones on 
brain  development  using  data  obtained  from  studies  of  maternal  hypothyroidism  and  maternal 
hypothyroxinaemia, although as with the previous studies, these subjects were not iodine deficient [9]. 
They  suggest  that  decreased  thyroid  hormones  early  in  pregnancy  may  cause  problems  in  visual 
attention,  visual  processing,  and  gross  motor  skills,  while  a  lack  of  thyroid  hormones  later  in 
pregnancy results in further problems with visual skills, slower processing speeds, and fine motor 
skills. Together, these observational studies provide evidence that a variation in maternal hormones 
influence normal brain development. Whether similar findings would occur in women with healthy 
thyroids but who are iodine deficient, needs further investigation.  
In  summary,  it  is  clear  that  low  concentrations  of  maternal  T4,  in  particular,  can  hinder  the 
development of the fetal brain. If severe to moderate iodine deficiency is present, the damage to the 
developing brain in the first half of pregnancy is caused by hypothyroxinemia of a euthyroid mother, Nutrients 2011, 3  
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which can continue in the second half of pregnancy and is then further aggravated by hypothyroidism 
in the fetus. It is uncertain, however, if this occurs in situations of moderate or mild iodine deficiency 
resulting from low dietary intakes.  
3. Determining the Severity of Iodine Deficiency in Pregnancy 
One of the problems in this area of research is the difficulty in determining the severity of iodine 
deficiency  in  pregnant  women.  The  mostly  commonly  used  index  for  assessing  iodine  status  in 
a population is the median urinary iodine concentration (MUIC) as determined from a casual or spot 
urine  sample.  A  MUIC  >  100  µ g/L  is  indicative  of  adequate  iodine  status  in  children,  men  and  
non-pregnant  women,  with  a  MUIC  of  50–99  µ g/L,  20–49  µ g/L,  and  <20  µ g/L  indicating  mild, 
moderate,  and  severe  iodine  deficiency,  respectively  [10].  In  2007,  WHO  recommended 
a MUIC > 150 µ g/L be used in pregnancy, however, no cut-offs for the severity of iodine deficiency in 
pregnancy have been proposed [10]. Because of this, researchers usually assume that the severity of 
iodine deficiency in pregnant women will be similar to the severity of iodine deficiency observed in 
children and adults living in the same region. For example, if moderate iodine deficiency exists in 
children,  then  pregnant  women  living  in  that  area  are  also  considered  to  be  moderately  iodine 
deficient. This view has some justification because cretinism is observed in areas of severe iodine 
deficiency but does not occur in areas of moderate to mild iodine deficiency, hence, pregnant women 
living in such areas must have less severe iodine deficiency (i.e., moderate to mild). Given the large 
variability in the iodine concentration of casual urine samples, the iodine status of an individual cannot 
be determined from a casual urine sample. In other words, a pregnant woman cannot be classified as 
iodine deficient based on her urinary iodine concentration [11].  
Pregnant women can have their thyroid hormones measured, with TSH and fT4 typically used to 
define subclinical hypothyroidism (TSH > 97.5th percentile, fT4 in normal reference range), overt 
hypothyroidism (TSH > 97.5th percentile and fT4 < 2.5th percentile), and hypothyroxinemia (TSH in 
normal reference range, fT4 < 2.5th percentile) [12]. There is debate as to whether all pregnant women 
should be screened for abnormal thyroid hormone concentrations in the first trimester. Changes in 
thyroid hormones can be caused by a variety of factors such as thyroid disease, and is not specific to 
iodine deficiency. Indeed, WHO do not recommend the routine use of TSH, T4 and T3 for monitoring 
iodine status in the adult population as these tests are relatively insensitive in moderate to mild iodine 
deficiency; MUIC provides sufficient information to assess iodine status in these groups. However, 
because  of  the  importance  of  maternal  thyroid  hormone  concentrations  for  normal  fetal  brain 
development, the establishment of trimester specific international reference ranges for thyroid hormones 
in iodine sufficient and deficient pregnant women could be useful in identifying at-risk women. 
4. The Effect of Severe Iodine Deficiency in Pregnancy on Neurodevelopment in the Child 
Severe iodine deficiency exists when more than 30% of children have goitre, the population has a 
MUIC < 20 µ g/L, and pregnant women living in the area give birth to cretins. Cretinism is always 
associated with a significant impairment in mental function and/or defects in hearing, speech, stance, 
gait, hypothyroidism and growth [13]. There are two types of cretinism, although the symptoms of 
both types can sometimes be seen in the same individual. The more common form of cretinism is Nutrients 2011, 3  
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neurological cretinism, characterised by mental retardation, deaf mutism, squint, spastic diplegia, and 
disorders of the stance and gait. The less common form of cretinism is called myxoedematous or 
hypothyroid  cretinism  and  is  characterised  by  less  severe  mental  retardation,  dwarfism, 
hypothyroidism, and a variety of other physical symptoms such as coarse and dry skin, a husky voice, 
and delayed sexual maturation. Normal IQ in a population is 100, while the IQ of cretins has been 
reported  to  be  around  30  [14].  In  areas  with  endemic  cretinism,  around  5–15%  of  non-cretinous 
children  will  have  impaired  mental  function  with  an  IQ  of  50–69;  these  children  are  sometimes 
referred to as “sub-cretins” [13]. Although factors such as the presence of goitrogens in the diet, 
thyroid  auto  immunity,  and  interactions  with  other  trace  elements  such  as  selenium  have  been 
postulated  to  have  a  role  in  the  development  and  type  of  cretinism,  the  overarching  reason  for 
cretinism is severe iodine deficiency in the mother [15]. The importance of adequate dietary iodine in 
preventing cretinism was highlighted in the 1960s in a large trial of 165,000 people living in a part of 
Papua New Guinea with severe iodine deficiency and endemic cretinism [16]. In this study, it was 
found that an injection of iodised oil before conception or in early pregnancy reduced the incidence of 
cretinism and improved the motor and cognitive functions of children compared with those women 
who received the placebo. Another study undertaken in 1990 in a remote province in China with 
endemic  cretinism  examined  the  effect  of  iodised  oil  given  during  pregnancy  on  neurological 
outcomes. Children of mothers given iodine earlier in pregnancy had improved cognitive outcomes 
compared to mothers given iodine later in pregnancy at both two years [17] and again when children 
were school-aged [18]. A meta-analysis of Chinese studies reported a decrease of 8.7 IQ points in 
children born to mothers living in severely iodine deficient areas untreated in pregnancy compared to 
supplemented mothers also living in severely iodine deficient areas [19]. 
It is unequivocal that severe iodine deficiency in pregnancy results in significant impairment in 
cognition in the child. It has been suggested that cretinism is at the far end of a spectrum of effects that 
iodine deficiency can have on the central nervous system, and that varying degrees of intellectual 
impairment  can  occur  across this  spectrum concordant  with  the degree of  iodine deficiency.  This 
theory has yet to be substantiated. 
5.  The  Effect  of  Moderate  to  Mild  Iodine  Deficiency  in  Pregnancy  on  Neurodevelopment  
in the Child 
A number of clinical trials published between 1991 and 2002 in pregnant women living in regions 
with moderate deficiency are summarized in Table 1 [20–27]. Daily iodine supplements ranging from 
100 to 300 µ g of iodine were taken by women in their first or second trimester of pregnancy. The 
majority of the studies showed that iodine supplements were effective in alleviating aspects of iodine 
deficiency in supplemented women compared to those taking the placebo. With regard to these studies, 
iodine  expert  Dr.  Michael  Zimmermann  wrote  “…because  none  of  the  trials  measured  long-term 
clinical  outcomes,  such  as  maternal  goiter  or  infant  development,  the  potential  adverse  effects  of  
mild-to-moderate iodine deficiency during pregnancy remain unclear” [28]. In 2009, two randomised 
trials were published investigating the effect of iodine supplementation in moderately iodine deficient 
pregnant  women  on  neurodevelopment  in  their  children.  Berbel  et  al.  recruited  three  groups  of 
pregnant  women  living  in  Spain  at  different  phases  of  gestation;  the  first  group  of  women  had Nutrients 2011, 3  
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T4 concentrations >20th percentile at recruitment (i.e., >0.92 ng/dL at 4–6 weeks gestation), while the 
second  and  third  groups  of  women  had  T4  concentrations  <10th  percentile  (i.e.,  <0.83  ng/dL)  at  
12–14 weeks gestation and near term, respectively. All three groups of women were supplemented 
with 200 µ g of iodine until the end of lactation [26]. When the children were 18 months old, the 
development quotient of children in mothers supplemented in the first group (i.e., 4–6 weeks) was 
significantly higher than that of children whose mothers received supplements from 12–14 weeks 
gestation and near term. A limitation of this study is the small numbers of children tested, with less 
than 20 children in each of the three groups. Furthermore, the women supplemented later in pregnancy 
or at term were specifically selected because they had low fT4 (i.e., <10th percentile) in pregnancy, 
while the women supplemented earlier in pregnancy had a higher fT4 (i.e., >20th percentile), thus  
a difference in fT4 rather than the iodine supplementation may account for the findings. A second 
Spanish study conducted in an area of moderate iodine deficiency (i.e., UIC of pregnant women in this 
area was <100 µ g/L) by Velasco et al. found that children of mothers supplemented with 300 µg  of 
iodine in the first trimester had higher psychomotor development scores than children from mothers 
who did not start supplementation until the last month of pregnancy [27]. A limitation of this study 
was that children were tested at different ages in this study (5.5 months vs. 12.4 months). Finally, both 
studies were not randomized, double-blind, placebo-controlled trials, and although they suggest that 
neurodevelopment in the child may be adversely affected by moderate iodine deficiency, they are 
certainly not definitive. 
Table 1. Studies investigating the effect of iodine supplementation in pregnancy. 
Author (Year)  Country  n  Methods 
Baseline 
UIC µ g/L 
Effect on child 
neurodevelopment 
Romano et al. 
(1991) [21]  
Italy  35  Women in first trimester randomised to 
0 or iodine supplement  
(120–180 µ g I/day). 
37  Not assessed. 
           
Pedersen et al. 
(1993) [22] 
Denmark  54  Women at 17–18 weeks gestation 
randomised to 0 or 200 µ g I/day. 
55  Not assessed. 
           
Glinoer et al. 
(1995) [23] 
Belgium  120  Euthyroid women with signs of 
excessive thyroid stimulation 
randomised to 0 or 100 µ g I/day. 
36  Not assessed. 
           
Liesenkotter et al. 
(1996) [20] 
Germany  118  Women at 10–12 weeks gestation 
given 300 µ g I/day vs. untreated 
women.  
53  Not assessed. 
           
Nohr and Laurberg 
(2000) [24] 
Denmark  144  Retrospective allocation at term based 
on self-reported intake of supplements 
containing 150 µg  I/day. 
Not given  Not assessed. 
           
Antonangeli et al. 
(2002) [25] 
Italy  86  Healthy women 10–16 weeks gestation 
randomised to 50 or 200 µ g I/day. 
74  Not assessed. Nutrients 2011, 3  
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Table 1. Cont. 
Berbel et al. 
(2009) [26] 
Spain  96  Women 4–6 weeks gestation with 
FT4 > 20th percentile (Group1) vs. 
women with FT4 < 10th percentile 
at 12–14 weeks (Group 2) or at  
37–40 weeks (Group3) given 
200 µg  I/day until end of lactation.  
75  Brunet-Lezine 
developmental quotient of 
children at 18 months was: 
101.8 in Group 1 vs. 92.2 
in Group 2 (p < 0.05) or 
87.5 in Group 3 
(p < 0.001). 
           
Velasco et al. 
(2009) [27] 
Spain  191  Women <10 weeks gestation 
(Group 1) vs. last month of 
pregnancy (Group 2) given 
300 µg  I/day until end of lactation. 
87  Bayley Psychomotor 
Development Index of 
children was: 108.74 in 
Group 1 vs. 102.65 in 
Group 2 (p = 0.02). 
UIC: urinary iodine concentration; TSH: Thyroid Stimulating Hormone; FT4: Free Thyroxine. 
The consequences of milder types of iodine deficiency (i.e., MUIC 100–150 µ g/L) in pregnancy 
have yet to be elucidated. In countries, such as Australia and New Zealand, which have seen the  
re-emergence of mild iodine deficiency in the last two decades, there appears to be no obvious signs of 
impaired neurodevelopment over this period with children meeting the usual developmental milestones 
at appropriate times. It is possible that in mild iodine deficiency adaptive mechanisms conserve iodine 
in the mother, such that the mother can supply the infant with sufficient thyroid hormones for normal 
brain development; the parasitic nature of the fetus in pregnancy is well known. To date, there are no 
published studies examining the effect of iodine supplementation in mildly iodine deficient pregnant 
women  on  neurodevelopment  in  children,  however,  by  2015  the  results  of  ongoing  randomised, 
placebo-controlled, intervention trials being conducted in Thailand and India [29] should be available. 
Conducting such trials will become increasingly difficult in the coming years for a number of reasons: 
firstly, the promotion of strategies to improve iodine status will result in more populations becoming 
iodine sufficient around the world and less populations with iodine deficiency; and secondly, giving 
a placebo  with  no  iodine  to  a  group  of  women  with  iodine  deficiency  has  been  suggested  to  be 
unethical.  This  view  is  premature  given  the  paucity  of  evidence  and  counters  the  philosophy  of 
evidence-based health care. 
6. Conclusion 
Severe iodine deficiency during pregnancy is a known cause of cretinism and mental retardation. 
At present,  there  are  limited  data  on  the  cognitive  deficits  of  children  born  to  mothers  who  are 
moderately iodine deficient in pregnancy. There is a need for well designed clinical trials investigating 
whether routine iodine supplementation of pregnant women living in regions of mild iodine deficiency 
improves neurodevelopment in children.  
   Nutrients 2011, 3  
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